Last update 21 Nov 2024

Chlorobenzopiperidone Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
PAF receptor
Mechanism
PAF receptor antagonists(Platelet activating factor receptor antagonists)
Therapeutic Areas
Immune System DiseasesNervous System DiseasesSkin and Musculoskeletal Diseases
Active Indication
Pain, PostoperativeRheumatoid Arthritis
Inactive Indication-
Originator Organization
Institute of Materia MedicaInstitute of Materia Medica
Active Organization
Institute of Materia MedicaInstitute of Materia MedicaBeijing Sciecure Pharmaceutical Co., Ltd.Beijing Sciecure Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Chlorobenzopiperidone Hydrochloride
CTR20191715 / RecruitingPhase 2
盐酸氯苯哌酮片对 （全或半）髋/膝关节置换术后镇痛效果的探索及群体药代动力学研究
[Translation] Exploration of the analgesic effect of clopidogrel hydrochloride tablets on postoperative analgesia after (total or partial) hip/knee replacement and population pharmacokinetic study
CTR20181161 / RecruitingPhase 2
不同剂量盐酸氯苯哌酮片对髋膝关节置换术后镇痛效果的探索性临床试验
[Translation] An exploratory clinical trial of different doses of clopidogrel hydrochloride tablets for analgesia after hip and knee replacement surgery
100 Clinical Results associated with Chlorobenzopiperidone Hydrochloride
Login to view more data
100 Translational Medicine associated with Chlorobenzopiperidone Hydrochloride
Login to view more data
100 Patents (Medical) associated with Chlorobenzopiperidone Hydrochloride
Login to view more data
100 Deals associated with Chlorobenzopiperidone Hydrochloride
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pain, PostoperativePhase 2
CN
Beijing Sciecure Pharmaceutical Co., Ltd.Beijing Sciecure Pharmaceutical Co., Ltd.
23 May 2019
Pain, PostoperativePhase 2
CN
Institute of Materia MedicaInstitute of Materia Medica
23 May 2019
Rheumatoid ArthritisPhase 2
CN
Institute of Materia MedicaInstitute of Materia Medica
-
Rheumatoid ArthritisPhase 2
CN
Beijing Sciecure Pharmaceutical Co., Ltd.Beijing Sciecure Pharmaceutical Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free